Channing Judith Paller MD
Genitourinary Oncology, Hematologic Oncology
Associate Professor of Oncology, Director of Prostate Cancer Clinical Research, Oncology Director John Hopkins Clinical Research Network, Johns Hopkins University School of Medicine
Join to View Full Profile
5255 Loughboro Rd NWWashington, DC 20016
Phone+1 410-955-7963
Fax+1 202-660-6501
Dr. Paller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2008 - 2011- Johns Hopkins UniversityResidency, Internal Medicine, 2005 - 2008
Harvard Medical SchoolClass of 2005, MD
Certifications & Licensure
FL State Medical License 2021 - Present
DC State Medical License 2012 - 2027
VA State Medical License 2021 - 2026
MD State Medical License 2008 - 2025
PA State Medical License 2020 - 2022
AL State Medical License 2020 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Medical OncologyInternal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Clinical Trials
- Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Start of enrollment: 2011 Jul 01
- S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
- Trial of Mistletoe Extract in Patients With Advanced Solid Tumors Start of enrollment: 2017 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes.Yasaman Iranmanesh, Noha Omar, Arya Rasouli, Alex Baras, Sergiu Pasca
The Oncologist. 2025-04-04 - Harnessing nature's therapeutic potential: A review of natural products in prostate cancer management.Nicole A Metri, Adel Mandl, Channing J Paller
Urologic Oncology. 2025-04-01 - 1 citationsThe ENGAGE study: evaluation of a conversational virtual agent that provides tailored pre-test genetic education to cancer patients.Kala Visvanathan, Dana Petry, Michelle S McCullough, Betty May, Ramkrishnan Tenkasi
Journal of Cancer Survivorship. 2025-04-01
Journal Articles
- Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate CancerChanning J Paller, Otis Brawley, JAMA Oncology
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate CancerEmmanuel S Antonarakis, Ashley E Ross, Michael A Gorin, Samuel R Denmeade, Channing J Paller, Kenneth J Pienta, Mario A Eisenberger, JAMA Oncology
- TGF‐Β Receptor I Inhibitor Enhances Response to Enzalutamide in a Pre‐Clinical Model of Advanced Prostate CancerChanning Paller, Cameron A Wade, The Prostate
Press Mentions
Enzalutamide May Have Slight Survival Advantage over Abiraterone for mCRPCAugust 19th, 2024- Johns Hopkins Study Highlights Promise of IV Mistletoe Extract for Cancer Therapy – the Mercury NewsMarch 24th, 2023
- Johns Hopkins Study Highlights Promise of IV Mistletoe Extract for Cancer Therapy – Twin CitiesMarch 24th, 2023
- Join now to see all
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/channing-paller
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
